Journal of Thoracic Disease · 2017 · 11 citations · 9 references
MedicineOncologyPathologyMolecular OncologyMolecular PathologyNeoplasiaLung CancerMalignant NeoplasmsMolecular Classification Of TumorsPulmonary PathologySoft Tissue SarcomasTumor ClassificationClinical Next-generation SequencingHistiocytic SarcomaMtor InhibitionMtor SignalingPulmonary NeoplasiaPulmonary NeoplasmsSoft Tissue Sarcoma TreatmentTarget Gene Mutations
Malignant fibrous histiocytoma (MFH) is an aggressive soft tissue sarcoma known to occur in various organs. Primary MFH arising in the lung is quite rare. Herein we report a case of a 61-year-old male with primary pulmonary MFH and explore the underlying molecular mechanisms by next-generation sequencing (NGS). Five gene mutations in TSC2, ARID1B, CDK8, KDM5C and CASP8 were detected, and the mTOR inhibitor might be an effective treatment for this patient. In addition, we reviewed the scientific literature of approximately 23 primary pulmonary MFH case reports since 1990 and summarized the clinical features and prognosis of this rare pulmonary malignant tumor.
9
Malignant fibrous histiocytoma of the lung: Report of four cases and review of the literature
Michele Y. Halyard, John Camoriano, John A. Culligan et al. · Cancer · 1996 · 42 citations · Full text
Malignant fibrous histiocytoma of the lung in a child
Manuel Nistal, José A. Jiménez‐Heffernan, David Hardisson et al. · European Journal of Pediatrics · 1997 · 16 citations
Medicine, Pathology, Pediatrics +12